| LIST OF ANTIBODIES: ORDER INFORMATION, SHIPPING AND STORAGE |
| order # |
product |
reactive* |
applic.* |
description |
amount |
| 2215PR |
Anti-Acinus (CP) |
h. m. |
WB |
Inducer of chromatin condensation |
100 µg |
| 24170SB |
Anti-Acinus (CT)** |
h. |
WB,IHC |
Inducer of chromatin condensation |
100 µg |
| 2217PR |
Anti-Acinus (CT)** |
h. |
WB |
Inducer of chromatin condensation |
100 µg |
| 2219PR |
Anti-Acinus (IN) |
h. |
WB |
Inducer of chromatin condensation |
100 µg |
| 2241PR |
Anti-Acinus (NP) |
h. |
WB |
Inducer of chromatin condensation |
100 µg |
| 24169SB |
Anti-Acinus (NT) |
h. |
WB,IHC |
Inducer of chromatin condensation |
100 µg |
| 2051PR |
Anti-ADAM10 (CT) |
h. |
WB |
TNF-alpha converting enzyme |
100 µg |
| 2301PR |
Anti-AIF (CT) |
h. m. r. |
WB |
Apoptosis inducing factor |
100 µg |
| 2267PR |
Anti-AIF (IN) |
h. m. r. |
WB |
Apoptosis inducing factor |
100 µg |
| 2239PR |
Anti-AIF (NT) |
h. |
WB |
Apoptosis inducing factor |
100 µg |
| 2015PR |
Anti-Apaf-1 (CT) |
h. |
WB |
Apoptosis protease activ. factor |
100 µg |
| 2013PR |
Anti-Apaf-1 (NT) |
h. |
WB |
Apoptosis protease activ. factor |
100 µg |
| 2223PR |
Anti-APRIL (ED) |
h. |
WB |
A new member in the TNF family |
100 µg |
| 2415PR |
Anti-APRIL (ED2 |
h. |
WB |
A new member in the TNF family |
100 µg |
| 2081PR |
Anti-ARC (CT) |
h. |
WB |
Apoptosis repressor |
100 µg |
| 2185PR |
Anti-ARC (NT) |
h. m. r. |
WB |
Apoptosis repressor |
100 µg |
| 3305PR |
Anti-ARMER (CT) (ARL6IP, AIPI) |
h. m. |
WB |
An inhibitor of apoptosis |
100 µg |
| 3025PR |
Anti-ARTS |
h. |
WB |
An Apoptosis related protein |
100 µg |
| 2287PR |
Anti-ASC |
h. |
WB |
New CARD-containing adaptor protein |
100 µg |
| 1151PR |
Anti-ASK1 (CT) |
h. |
WB |
MAPK kinase kinase |
100 µg |
| 3343PR |
Anti-Bad (Bcl-2-like 8) |
h. m. r. |
WB, IHC |
Bcl-2 family member |
100 µg |
| 2221PR |
Anti-BAFF (CT) |
h. m. r. |
WB |
B cell activating factor in TNF family |
100 µg |
| 3097PR |
Anti-BAFF-R (CT) |
h. m. r. |
WB |
Receptor for BAFF |
100 µg |
| 3347PR |
Anti-Bak (NT) |
h. m. |
WB |
A member of the bcl-2 family |
100 µg |
| 3351PR |
Anti-Bax (NT) |
h. |
WB |
A member of the bcl-2 family |
100 µg |
| 3335PR |
Anti-Bcl2 (NT) |
h. m. |
WB, IHC |
A member of the bcl-2 family |
100 µg |
| 3337PR |
Anti-Bcl2 (IN) |
h. |
WB |
A member of the bcl-2 family |
100 µg |
| 24129SB |
Anti-Bcl10 (CT) |
h. |
WB,IHC |
Involved in apoptosis |
100 µg |
| 2161PR |
Anti-Bcl10 (NT) |
h. |
WB |
Involved in apoptosis |
100 µg |
| 3165PR |
Anti-Bcl-G (CT) (Bcl-2-like 14) |
h. m. r. |
WB |
Bcl-2 family member |
100 µg |
| 3341PR |
Anti-Bcl-xL |
h. |
WB |
A member of the bcl-2 family |
100 µg |
| 24209SB |
Anti-BCL-G (CT) |
h. |
WB,IHC |
Novel pro-apoptotic member of the BCL-2 family |
100 µg |
| 24210SB |
Anti-BCL-G (NT) |
h. |
WB,IHC |
Novel pro-apoptotic member of the BCL-2 family |
100 µg |
| 2397PR |
Anti-BCMA |
h. |
WB |
Receptor for BAFF and APRIL |
100 µg |
| 3353PR |
Anti-Bid (CT) |
h. m. |
WB |
A member of the bcl-2 family |
100 µg |
| 3355PR |
Anti-Bid (IN) |
h. m. |
WB |
A member of the bcl-2 family |
100 µg |
| 2065PR |
Anti-Bim (IN) |
h. m. r. |
WB |
New member in Bcl-2 family |
100 µg |
| 3405PR |
Anti-BIM (IND2) (BOD) |
h. m. r. |
WB |
An intermediate in the TLR and Bmp signaling pathway |
100 µg |
| 3029PR |
Anti-Bmf (CT) |
h. |
WB |
New member in Bcl-2 family |
100 µg |
| 3031PR |
Anti-Bmf (NT) |
h. m. |
WB |
New member in Bcl-2 family |
100 µg |
| 2289PR |
Anti-Bnip3L (IN) |
h. |
WB |
A new member in Bcl-2 family |
100 µg |
| 2011PR |
Anti-CAD (CT) |
m. |
WB |
Caspase activated DNase |
100 µg |
| 2007PR |
Anti-CAD (I17) |
m. |
WB |
Caspase activated DNase |
100 µg |
| 3187PR |
Anti-CARD8 (Cardinal/TUCAN) |
h. |
WB |
New CARD-containing protein |
100 µg |
| 3189PR |
Anti-CARMA1 |
h. m. |
WB |
Lymphocyte activating CARD-containing protein |
100 µg |
| 2515PR |
Anti-CARD9 |
h. |
WB |
New CARD-containing protein |
100 µg |
| 1128PR |
Anti-Casp-10 (CT) |
h. m. |
WB |
Caspase-activating protease |
100 µg |
| 24300SB |
Anti-Casp-10 (NT) |
h. |
WB,IHC |
Caspase-activating protease |
100 µg |
| 2327PR |
Anti-Casp-12 (IN) |
h. m. r. |
WB |
A new caspase |
100 µg |
| 2325PR |
Anti-Casp-12 (NT) |
h. m. r. |
WB |
A new caspase |
100 µg |
| 3197PR |
Anti-Casp12 (sml) |
h.m.r. |
WB |
A new caspase |
100 µg |
| 3195PR |
Anti-Casp12 (lrg) |
h.m.r. |
WB |
A new caspase |
100 µg |
| 2245PR |
Anti-Casp-13 (CT) |
h. m. r. |
WB |
Evolutionarily related ICE |
100 µg |
| 2071PR |
Anti-Casp-9 (I16) |
h. |
WB |
Caspase-3 activator |
100 µg |
| 2073PR |
Anti-Casp-9 (I20) |
h. |
WB |
Caspase-3 activator |
100 µg |
| 3325PR |
Anti-cIAP (CT) |
h. m. |
WB |
Apoptosis inhibitor protein |
100 µg |
| 2085PR |
Anti-CIDE-A (CT) |
h. |
WB |
Cell death activator |
100 µg |
| 24316SB |
Anti-CIDE-3 |
h. |
WB, IHC |
Cell death activator |
100 µg |
| 24264SB |
Anti-CLAN Protein |
h. |
WB,IHC |
CARD-containing, apoptosis-regulating protein |
100 µg |
| 3313PR |
Anti-DAD1 |
h.m. |
WB |
An inhibitor of apoptosis |
100 µg |
| 2323PR |
Anti-DAPK2 |
h. m. r. |
WB |
Death-associated protein kinase 2 |
100 µg |
| 1163PR |
Anti-Daxx (CT) |
h. m. |
WB |
Cell death adapter molecule |
100 µg |
| 2179PR |
Anti-DcR1 (CT) |
h. |
WB |
Decoy receptor 1 for TRAIL |
100 µg |
| 2299PR |
Anti-DcR1 (ED2) |
h. m. r. |
WB |
Decoy receptor for TRAIL |
100 µg |
| 2023PR |
Anti-DcR2 (CT) |
h. |
WB |
Decoy receptor for Trail |
100 µg |
| 2021PR |
Anti-DcR2 (ID) |
h. |
WB |
Decoy receptor for Trail |
100 µg |
| 2140PR |
Anti-DcR3/TR6 |
h. |
WB |
Decoy receptor for FASL & LIGHT |
100 µg |
| 2227PR |
Anti-DEDAF |
h. m. |
WB |
Novel caspase-interacting protein |
100 µg |
| 24281SB |
Anti-DEDD2 |
h. |
IHC |
Involved in the regulation of nuclear events |
100 µl |
| 2155PR |
Anti-DFF40 (IN) |
h. |
WB |
Caspase activated DNase |
100 µg |
| 2153PR |
Anti-DFF40 (NT) |
h. |
WB |
Caspase activated DNase |
100 µg |
| 2107PR |
Anti-DFF40/CAD (I18) |
m. |
WB |
Caspase activated DNase |
100 µg |
| 1141PR |
Anti-DFF45 (CT) |
h. |
WB |
DNA fragmentation factor |
100 µg |
| 1148PR |
Anti-DFF45 (NT) |
h. |
WB |
DNA fragmentation factor |
100 µg |
| 24267SB |
Anti-DIABLO (CT) |
h. |
WB,IHC |
Promotes apoptosis by binding to IAPs |
100 µg |
| 2057PR |
Anti-DNase II (IN) |
h. |
WB |
DNase involved in apoptosis |
100 µg |
| 2059PR |
Anti-DNase ll (CT) |
h. |
WB |
DNase involved in apoptosis |
100 µg |
| 1120PR |
Anti-DR3 (CT) |
h. |
WB |
Cell death receptor |
100 µg |
| 1158PR |
Anti-DR3 (ED) |
h. |
WB |
Cell death receptor |
100 µg |
| 1166PR |
Anti-DR3 (NT) |
h. |
WB |
Cell death receptor |
100 µg |
| 1139PR |
Anti-DR4 (CT) |
h. |
WB |
Death receptor for TRAIL |
100 µg |
| 1167PR |
Anti-DR4 (NT) |
h. |
WB |
Death receptor for Trail |
100 µg |
| 2019PR |
Anti-DR5 (CT) |
h. m. |
WB |
Death receptor for Trail |
100 µg |
| 2157PR |
Anti-DR6 (NT) |
h. |
WB |
Death receptor 6 |
100 µg |
| 2147PR |
Anti-DRAK1 (NT) |
h. |
WB,IHC |
Apoptosis inducing kinase |
100 µg |
| 2149PR |
Anti-DRAK2 (CT) |
h. |
WB |
Apoptosis inducing kinase |
100 µg |
| 3035PR |
Anti-EndoG |
h.m.r. |
WB |
Endonuclease G |
100 µg |
| 2279PR |
Anti-F1 alpha (CT) |
h. m. r. |
WB |
Novel death receptor binding protein |
100 µg |
| 2271PR |
Anti-FLASH (CT) |
h. |
WB |
Involved in Fas induced apoptosis |
100 µg |
| 24167SB |
Anti-FLASH (NT) |
h. |
WB,IHC |
Involved in Fas induced apoptosis |
100 µg |
| 1159PR |
Anti-FLIP (NT) |
h. |
WB |
FLICE inhibitory protein |
100 µg |
| 1161PR |
Anti-FLIPa (CT) |
h. m. |
WB |
FLICE inhibitory protein |
100 µg |
| 2055PR |
Anti-FLIPg/d (CT) |
h. |
WB |
FLICE inhibitory protein |
100 µg |
| 24272SB |
Anti-GRIM-19 |
h. |
WB,IHC |
Novel cell death regulatory molecule |
100 µg |
| 2003PR |
Anti-ICAD (CT) |
m. |
WB |
Inhibitor of CAD |
100 µg |
| 2001PR |
Anti-ICAD (NT) |
m. |
WB |
Inhibitor of CAD |
100 µg |
| 3107PR |
Anti-Ipaf (CARD12/CLANA) |
h. |
WB |
ICE protease activating factor |
100 µg |
| 24276SB |
Anti-ILP-1 |
h. |
WB,IHC |
Potent inhibitor of apoptosis |
100 µg |
| 3017PR |
Anti-ILP-2 |
h.m.r. |
WB |
A new member in IAP family |
100 µg |
| 3201PR |
Anti-ILPIP (CT) |
h. |
WB |
An IAP binding protein |
100 µg |
| 3199PR |
Anti-ILPIP (IN) |
h. m. r. |
WB |
An IAP binding protein |
100 µg |
| 24207SB |
Anti-Livin (NT) |
h. |
IHC |
A new member in IAP family |
100 µg |
| 2505PR |
Anti-Livin, KIAP |
h. |
WB |
A new member in IAP family |
100 µg |
| 24271SB |
Anti-MAP-1 |
h. |
WB,IHC |
Modulator of apoptosis |
100 µg |
| 2089PR |
Anti-mCIDE-A (CT) |
m. |
WB |
Cell death activator |
100 µg |
| 2091PR |
Anti-mCIDE-B CT) |
m. |
WB |
Cell death activator |
100 µg |
| 1156PR |
Anti-mFLIP (CT) |
h. |
WB |
FLICE inhibitory protein |
100 µg |
| 2411PR |
Anti-mSmac (CT) |
h. m. r. |
WB |
(DIABLO) IAPs binding protein |
100 µg |
| 2237PR |
Anti-mSurvivin (CT) |
m. |
WB |
New inhibitor of apoptosis |
100 µg |
| 3359PR |
Anti-NADE |
h. m. |
WB |
A novel apoptosis related protein |
100 µg |
| 3315PR |
Anti-NAIP (CT) |
h. |
WB |
Neuronal apoptosis inhibitor protein |
100 µg |
| 24329SB |
Anti-NORE1 |
h. r. m. |
WB, IHC |
Ras effector, member of RASSF1 gene family |
100 µg |
| 3319PR |
Anti-OMI (Htr2A) |
h. |
WB |
IAP inhibitor |
100 µg |
| 3152PR |
Anti-PHAP (CT) |
h.m.r. |
WB |
Regulator of mitochondrion apoptosis |
100 µg |
| 3149PR |
Anti-PHAP (NT) |
h. m. r. |
WB |
Regulator of mitochondrion apoptosis |
100 µg |
| 3151PR |
Anti-PHAP I (CT) |
h. m. r. |
WB |
Regulator of mitochondrion apoptosis |
100 µg |
| 3147PR |
Anti-PHAP III |
h. m. r. |
WB |
Regulator of mitochondrion apoptosis |
100 µg |
| 3321PR |
Anti-PIKE (CT) (centaurin gamma 1) |
h. m. |
WB |
Apoptosis inhibitor |
100 µg |
| 24277SB |
Anti-PUMA |
h. m. |
WB,IHC |
A novel member in Bcl2-family |
100 µg |
| 3041PR |
Anti-PUMA (CT) |
h. m. |
WB |
A novel member in Bcl-2 family |
100 µg |
| 3043PR |
Anti-PUMA (NT) |
h. |
WB |
A novel member in Bcl-2 family |
100 µg |
| 1117PR |
Anti-RAIDD (CT) |
h. |
WB |
Cell death adapter molecule |
100 µg |
| 1115PR |
Anti-RAIDD (IN) |
h. |
WB |
Cell death adapter molecule |
100 µg |
| 2183PR |
Anti-RICK (CT) |
h. |
WB |
RIP-like interacting CLARP kinase |
100 µg |
| 2075PR |
Anti-RICK (NT) |
h. |
WB |
RIP-like interacting CLARP kinase |
100 µg |
| 2283PR |
Anti-RIP3 |
m. r. |
WB |
Mouse receptor interacting protein |
100 µg |
| 2409PR |
Anti-Smac (CT) |
h. m. r. |
WB |
(DIABLO) IAPs binding protein |
100 µg |
| 2143PR |
Anti-SODD (NT) |
h. |
WB |
Silencer of death domain |
100 µg |
| 24283SB |
Anti-Survivin |
h. |
WB,IHC |
New inhibitor of apoptosis |
100 µg |
| 2235PR |
Anti-Survivin (CT) |
h. |
WB |
New inhibitor of apoptosis |
100 µg |
| 2233PR |
Anti-Survivin (NT) |
h. |
WB |
New inhibitor of apoptosis |
100 µg |
| 1131PR |
Anti-TACE (CT) |
h. m. r. |
WB |
TNF-alpha converting enzyme |
100 µg |
| 2395PR |
Anti-TACI |
h. |
WB |
Receptor for BAFF and APRIL |
100 µg |
| 3109PR |
Anti-TL1A (NT) |
h. m. r. |
WB |
DR3 ligand |
100 µg |
| 1113PR |
Anti-TRAIL (CT)** |
h. |
WB |
Ligand for DR4 and DR5 |
100 µg |
| 24172SB |
Anti-TRAIL (CT)** |
h. |
WB,IHC |
Ligand for DR4 and DR5 |
100 µg |
| 24171SB |
Anti-TRAIL (NT) |
h. |
WB,IHC |
Ligand for DR4 and DR5 |
100 µg |
| 24296SB |
Anti-TRAIL-R2 |
h. |
IHC |
Novel TNF family member that induces apoptosis |
100 µl |
| 24297SB |
Anti-TRAIL-R3 |
h. |
IHC |
Novel TNF family member that induces apoptosis |
100 µl |
| 24298SB |
Anti-TRAIL-R4 |
h. |
WB,IHC |
Novel TNF family member that induces apoptosis |
100 µg |
| 3207PR |
Anti-XAF-1 (CT) |
h. m. |
WB |
Inhibitor of XIAP |
100 µg |
| 3409PR |
Anti-XAF-1 (IN) |
h. |
WB |
Inhibitor of XIAP |
100 µg |
| 3331PR |
Anti-XIAP (CT) |
h. m. |
WB |
Apoptosis inducing kinase |
100 µg |
| 2067PR |
Anti-ZIPK (IN) |
h. |
WB |
Apoptosis inducing kinase |
100 µg |
| 53 network |
| 2391PR |
Anti-Chk2 (NT) |
h. m. r. |
WB |
A novel check point kinase |
100 µg |
| 2447PR |
Anti-MTBP (IN2) |
h. |
WB |
MDM2 binding protein |
100 µg |
| 2451PR |
Anti-PERP (NT)** |
h. |
WB |
Mediator of p53 induced apoptosis |
100 µg |
| 24284SB |
Anti-PERP** |
h. |
WB,IHC |
Mediator of p53 induced apoptosis |
100 µg |
| 2443PR |
Anti-PID/MTA2 |
h. m. r. |
WB |
Involved in p53 deacetylation |
100 µg |
| 3045PR |
Anti-p53DINP1, SIP |
h.m.r. |
WB |
Apoptosis-associated p53 target |
100 µg |
| 2383PR |
Anti-p53R2 (NT) |
h. m. r. |
WB |
A novel ribonucleotide kinase |
100 µg |
| Toll-like receptors |
| 3395PR |
Anti-BTK (NT) (ATK, BPK) |
h. m. |
WB |
Bruton's Tyrosine Kinase |
100 µg |
| 3377PR |
Anti-ECSIT (CT) |
h. m. |
WB |
An intermediate in the TLR and Bmp signaling pathways |
100 µg |
| 3289PR |
Anti-MD-2 (IN) |
h. m. r. |
WB, IHC |
Toll-like receptor adaptor protein |
100 µg |
| 3295PR |
Anti-SARM (CT) |
h. m. |
WB, IHC |
Toll-like receptor adaptor protein |
100 µg |
| 3367PR |
Anti-SIGIRR (CT) |
h. m. |
WB |
A TLR inhibitor |
|
| 3363PR |
Anti-ST2 (NT) |
m. |
WB |
A TLR inhibitor |
100 µg |
| 3387PR |
Anti-TAB1 |
h. m. |
WB |
TAK1 binding protein |
|
| 3157PR |
Anti-TIRAP (CT) |
h. m. r. |
WB, IHC |
Toll-like receptor adaptor protein |
100 µg |
| 3155PR |
Anti-TIRAP (IN) (MAL) |
h. |
WB |
Toll-like receptor adaptor protein |
100 µg |
| 3206PR |
Anti-TIRP (CT) |
h. |
WB |
Toll-like receptor adaptor protein |
100 µg |
| 3299PR |
Anti-TIRP (C2) |
h. m. r. |
WB |
Toll-like receptor adaptor protein |
100 µg |
| 3135PR |
Anti-TLR2 (NT) |
h. m. |
WB, IHC |
Toll-like receptor |
100 µg |
| 3141PR |
Anti-TLR4 (NT) |
h. |
WB |
Toll-like receptor |
100 µg |
| 3269PR |
Anti-TLR7 (IN) |
h. m. |
WB |
Toll-like receptor protein |
100 µg |
| 3281PR |
Anti-TLR8 (IN) |
h. m. |
WB |
Toll-like receptor protein |
100 µg |
| 3275PR |
Anti-TLR10 (IN) |
h. |
WB |
Toll-like receptor protein |
100 µg |
| 3277PR |
Anti-TLR11 (CT) |
m. |
WB |
Toll-like receptor protein |
100 µg |
| 3285PR |
Anti-TLR11 (IN) |
m. |
WB |
Toll-like receptor protein |
100 µg |
| 3371PR |
Anti-TRIAD3A |
h. |
WB |
A TLR-ubiquitinating enzyme |
100 µg |
| 3173PR |
Anti-TRIF (TICAM-1) |
h. |
WB |
Toll-like receptor adaptor protein |
100 µg |
| 3373PR |
Anti-UBC13 (E2N) |
h. m. r. |
WB |
Ubiquitin conjugating enzyme 13 |
100 µg |
| 3375PR |
Anti-UEV1A |
h. m. r. |
WB |
An ubiquitin conjugating enzyme |
100 µg |
shipped on blue ice; stored at -20°C
(once thawed, stored at 4°C to avoid multiple freezing and thawing) |
Abbreviations: * h.: human, m.: mouse, r. : rat,
tested in: WB: Western blot, IP: immunoprecipitation,IHC: immunohistochemistry,
AI: apoptose induction, I: inhibition,
CT: C-terminus, NT: N-terminus, IN: intermediate domain, ED: extracellular domain,
ID: intracellular domain.
Control lysates of cell lines and tissues and blocking peptides are available for testing upon request.
**: different target antigens.
|